The Angiography Characteristic of Free Wall Ruptrue in STEMI

NCT ID: NCT04213599

Last Updated: 2020-01-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

14629 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-01-01

Study Completion Date

2020-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To analyze whether the location of myocardial infarction and infarct related artery are related to FWR.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To know the characteristic of FWR that different location of STEMI and coronary distribution

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

ST-Elevation Myocardial Infarction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Anterior infarction

Patients with anterior ST-elevation myocardial infarction

Coronary intervention

Intervention Type DIAGNOSTIC_TEST

Patients with STEMI undergo coronary intervention

Inferior infarction

Patients with inferior ST-elevation myocardial infarction

Coronary intervention

Intervention Type DIAGNOSTIC_TEST

Patients with STEMI undergo coronary intervention

Lateral infarction

Patients with lateral ST-elevation myocardial infarction

Coronary intervention

Intervention Type DIAGNOSTIC_TEST

Patients with STEMI undergo coronary intervention

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Coronary intervention

Patients with STEMI undergo coronary intervention

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients had to be ≥18 years of age, be admitted for STEMI
2. Accord with STEMI diagnostic criteria
3. STEMI patients anticipated to undergo angiography

Exclusion Criteria

1. Pregnant
2. Acute stroke
3. Aortic dissection
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Xiamen Cardiovascular Hospital, Xiamen University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Bin Wang

Ph D, Director

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bin Wang, PhD

Role: STUDY_DIRECTOR

Xiamen Cardiovascular Hospital, Xiamen University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Xiamen Cardiovascular Hospital Xiamen University

Xiamen, Fujian, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Bin Wang, PhD

Role: CONTACT

+8613400664305

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Xile Bi, Dr.

Role: primary

+8615930593145

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

9215443693

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.